Dietary intake of trans fatty acids and systemic inflammation in women
- PMID: 15051604
- PMCID: PMC1282449
- DOI: 10.1093/ajcn/79.4.606
Dietary intake of trans fatty acids and systemic inflammation in women
Abstract
Background: trans Fatty acid (TFA) intake predicts risks of coronary artery disease and diabetes. Systemic inflammation may be involved in the pathogenesis of such conditions; however, relations between TFA intake and systemic inflammation are not well established.
Objective: We investigated the relations between TFA intake and inflammatory markers.
Design: In 823 generally healthy women in the Nurses' Health Study I and II, concentrations of soluble tumor necrosis factor alpha receptors 1 and 2 (sTNF-R1, sTNF-R2), interleukin 6 (IL-6), and C-reactive protein (CRP) were measured. Usual dietary intakes assessed from 2 semiquantitative food-frequency questionnaires were averaged for each subject.
Results: In age-adjusted analyses, TFA intake was positively associated with sTNF-R1 and sTNF-R2 (P for trend < 0.001 for each): sTNF-R1 and sTNF-R2 concentrations were 10% (+108 pg/mL; 95% CI: 50, 167 pg/mL) and 12% (+258 pg/mL; 138, 377 pg/mL) higher, respectively, in the highest intake quintile than in the lowest. These associations were not appreciably altered by adjustment for body mass index, smoking, physical activity, aspirin and nonsteroidal antiinflammatory drug use, alcohol consumption, and intakes of saturated fat, protein, n-6 and n-3 fatty acids, fiber, and total energy. Adjustment for serum lipid concentrations partly attenuated these associations, which suggests that they may be partly mediated by effects of TFAs on serum lipids. TFA intake was not associated with IL-6 or CRP concentrations overall but was positively associated with IL-6 and CRP in women with higher body mass index (P for interaction = 0.03 for each).
Conclusions: TFA intake is positively associated with markers of systemic inflammation in women. Further investigation of the influences of TFAs on inflammation and of implications for coronary disease, diabetes, and other conditions is warranted.
Similar articles
-
trans fatty acids and systemic inflammation in heart failure.Am J Clin Nutr. 2004 Dec;80(6):1521-5. doi: 10.1093/ajcn/80.6.1521. Am J Clin Nutr. 2004. PMID: 15585763 Free PMC article.
-
Dietary fat intake and proinflammatory cytokine levels in patients with heart failure.J Card Fail. 2005 Oct;11(8):613-8. doi: 10.1016/j.cardfail.2005.06.434. J Card Fail. 2005. PMID: 16230265
-
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women.Circulation. 2003 Jul 15;108(2):155-60. doi: 10.1161/01.CIR.0000079224.46084.C2. Epub 2003 Jun 23. Circulation. 2003. PMID: 12821543
-
Health effects of trans-fatty acids: experimental and observational evidence.Eur J Clin Nutr. 2009 May;63 Suppl 2:S5-21. doi: 10.1038/sj.ejcn.1602973. Eur J Clin Nutr. 2009. PMID: 19424218 Review.
-
Trans fatty acids: are its cardiovascular risks fully appreciated?Clin Ther. 2014 Mar 1;36(3):315-21. doi: 10.1016/j.clinthera.2014.01.020. Clin Ther. 2014. PMID: 24636816 Review.
Cited by
-
A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1797-804. doi: 10.1167/iovs.12-11191. Invest Ophthalmol Vis Sci. 2013. PMID: 23412091 Free PMC article.
-
Multidimensional associations between nutrient intake and healthy ageing in humans.BMC Biol. 2022 Sep 1;20(1):196. doi: 10.1186/s12915-022-01395-z. BMC Biol. 2022. PMID: 36050730 Free PMC article.
-
High trans but not saturated fat beverage causes an acute reduction in postprandial vascular endothelial function but not arterial stiffness in humans.Vasc Med. 2016 Oct;21(5):429-436. doi: 10.1177/1358863X16656063. Epub 2016 Aug 23. Vasc Med. 2016. PMID: 27558396 Free PMC article. Clinical Trial.
-
The diversity of health effects of individual trans fatty acid isomers.Lipids. 2007 Sep;42(9):787-99. doi: 10.1007/s11745-007-3095-8. Epub 2007 Aug 11. Lipids. 2007. PMID: 17694343 Review.
-
Functional interaction between plasma phospholipid fatty acids and insulin resistance in leucocyte telomere length maintenance.Lipids Health Dis. 2020 Jan 17;19(1):11. doi: 10.1186/s12944-020-1194-1. Lipids Health Dis. 2020. PMID: 31952540 Free PMC article.
References
-
- Allison DB, Egan SK, Barraj LM, Caughman C, Infante M, Heimbach JT. Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc. 1999;99:166–74. - PubMed
-
- Hulshof KF, van Erp-Baart MA, Anttolainen M, et al. Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANS-FAIR Study. Eur J Clin Nutr. 1999;53:143–57. - PubMed
-
- Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. trans Fatty acids and coronary heart disease. N Engl J Med. 1999;340:1994–8. - PubMed
-
- Salmeron J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001;73:1019–26. - PubMed
-
- Katan MB, Zock PL, Mensink RP. trans Fatty acids and their effects on lipoproteins in humans. Annu Rev Nutr. 1995;15:473–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL34594/HL/NHLBI NIH HHS/United States
- R01 CA050385/CA/NCI NIH HHS/United States
- K08 HL075628/HL/NHLBI NIH HHS/United States
- DK07703/DK/NIDDK NIH HHS/United States
- R01 DE012102/DE/NIDCR NIH HHS/United States
- DE12102/DE/NIDCR NIH HHS/United States
- P30 DK046200/DK/NIDDK NIH HHS/United States
- T32DK07703/DK/NIDDK NIH HHS/United States
- R01 HL034594/HL/NHLBI NIH HHS/United States
- T32 DK007703/DK/NIDDK NIH HHS/United States
- CA40356/CA/NCI NIH HHS/United States
- HL24074/HL/NHLBI NIH HHS/United States
- CA50385/CA/NCI NIH HHS/United States
- R01 CA040356/CA/NCI NIH HHS/United States
- DK46200/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous